Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
24-26 June, 2025
Not Confirmed
Not Confirmed
09-11 June, 2025
Annual Outsourcing in ...Annual Outsourcing in CT
Not Confirmed
Not Confirmed
10-11 June, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
24-26 June, 2025
Industry Trade Show
Not Confirmed
09-11 June, 2025
Annual Outsourcing in ...Annual Outsourcing in CT
Industry Trade Show
Not Confirmed
10-11 June, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/excipient-market-overview-roquette-announces-restructuring-post-iff-pharma-buyout-who-fda-advance-regulatory-frameworks
19 Feb 2025
// FIERCE BIOTECH
https://www.fiercebiotech.com/biotech/novo-nordisk-sue-kbp-biosciences-alleged-fraudulent-claims-kidney-disease-drugs
27 Jun 2024
// Jonathan Gardner BIOPHARMADIVE
https://www.biopharmadive.com/news/novo-ocedurenone-kbp-terminate-study-charge-blood-pressure/719947/
16 Oct 2023
// GLOBENEWSWIRE
https://www.globenewswire.com//news-release/2023/10/16/2760508/0/en/Novo-Nordisk-to-acquire-ocedurenone-for-uncontrolled-hypertension-from-KBP-Biosciences.html
06 Jan 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/ocedurenone-kbp-5074-featured-at-asn-kidney-week-ocedurenone-is-a-potential-new-treatment-option-for-patients-with-uncontrolled-or-resistant-hypertension-and-advanced-ckd-301715194.html
16 Jun 2021
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2021/06/16/2248139/0/en/KBP-Biosciences-Announces-A-Greater-Than-10-mm-Hg-Systolic-Blood-Pressure-Reduction-in-The-BLOCK-CKD-Phase-2b-Study-of-KBP-5074-in-Advanced-Chronic-Kidney-Disease-Patients-with-Unc.html
18 Dec 2020
// CLINICALTRIALSARENA
https://www.clinicaltrialsarena.com/comment/kbp-biosciences-5074-blood-pressure/
ABOUT THIS PAGE